David C. Qian
Weifang Medical University(CN)The University of Texas MD Anderson Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)Emory University(US)Nantong University(CN)Quzhou City People's Hospital(CN)117th Hospital of People's Liberation Army(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Bioinformatics and Genomic Networks, Lung Cancer Treatments and Mutations, RNA modifications and cancer
Most-Cited Works
- → Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes(2017)774 cited
- → International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways(2015)306 cited
- → Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment(2019)214 cited
- → Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis(2016)178 cited
- → The Abscopal Effect: A Review of Pre-Clinical and Clinical Advances(2021)152 cited
- → Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk(2018)80 cited